Corp. SVP BioPharma Network

Corporate Vice President

Breakthroughs in IPF may lead to first approval in years

To Compete in Obesity, Late Entrants Invest Early in Manufacturing

TegMine Therapeutics Enters Collaboration with Boehringer Ingelheim to Advance Novel 2-Factor Antibody System for Cancer

Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim

Executive Director, ExpMED Oncology Targeted Therapy

Boehringer Ingelheim is a global leader in healthcare, and they are seeking an Executive Director for Experimental Medicine in Oncology Targeted Therapy. This role involves providing medical strategic leadership for early clinical development in immunotherapy and managing a team to ensure scientific and clinical excellence in their projects.

Executive Director, ExpMED Oncology Targeted Therapy (Remote)

Vice President, Cancer Immunology & Immune Modulation

Executive Directo, Clinical Development & Medical Affairs

Senior Vice President, Global Head Cancer Immunology & Immune Modulation

Executive Director, Global Epidemiology

Associate Director, Oncology

Sign up with Google

Sign in with Google